BioSuperior Technology

For biotech and pharma companies that have research or preclinical protein therapeutic candidates, BioSuperior provides sophisticated computational chemistry services that mitigate undesirable candidate properties such as low biopotency, product instability, high viscosity, and poor bioavailability. Unlike traditional approaches, we proactively identify and fix structural problems using scalable, cloud-based Computation Aided Design (CAD) tools, inexpensively and quickly. Our technology has been successfully applied to a wide range of protein therapeutics including protein and peptide hormones, monoclonal antibodies and other peptide and protein candidates.